🇺🇸 FDA
Patent

US 6132730

Combined tissue factor and factor VIIa methods and compositions for coagulation and tumor treatment

expired A61KA61K47/6435A61K47/6813

Quick answer

US patent 6132730 (Combined tissue factor and factor VIIa methods and compositions for coagulation and tumor treatment) held by The Board of Regents of the University of Texas System expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61K, A61K47/6435, A61K47/6813, A61P, A61P35/00